ALLR (STOCKS)
Allarity Therapeutics, Inc. Common Stock
$0.900000
-0.030200 (-3.25%)
Prev close: $0.930200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas H. Jensen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16.39M
- Employees
- 7
- P/E (TTM)
- -0.58
- P/B (TTM)
- 1.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $1.69M |
| Operating Expenses | $17.00M |
| Research and Development | $6.77M |
| Other Operating Expenses | $10.23M |
| Operating Income/Loss | -$17.00M |
| Income/Loss From Continuing Operations After Tax | -$15.31M |
| Income/Loss From Continuing Operations Before Tax | -$15.31M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$15.31M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.31M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $9.11 |
| Basic Average Shares | 14,758,088 |
| Assets | $20.80M |
| Current Assets | $20.47M |
| Prepaid Expenses | $1.80M |
| Other Current Assets | $18.67M |
| Noncurrent Assets | $330.00K |
| Fixed Assets | $330.00K |
| Liabilities | $8.79M |
| Current Liabilities | $8.79M |
| Accounts Payable | $4.60M |
| Other Current Liabilities | $4.18M |
| Noncurrent Liabilities | $0.00 |
| Equity | $12.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $12.01M |
| Liabilities And Equity | $20.80M |
| Net Cash Flow From Operating Activities | -$14.78M |
| Net Cash Flow From Operating Activities, Continuing | -$14.78M |
| Net Cash Flow From Investing Activities | $18.80M |
| Net Cash Flow From Investing Activities, Continuing | $18.80M |
| Net Cash Flow From Financing Activities | $15.12M |
| Net Cash Flow From Financing Activities, Continuing | $15.12M |
| Net Cash Flow | $19.14M |
| Net Cash Flow, Continuing | $19.14M |
| Comprehensive Income/Loss | -$16.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.92M |
| Other Comprehensive Income/Loss | -$16.92M |